(Total Views: 92)
Posted On: 09/16/2019 11:36:30 AM
Post# of 36281
$CYDY CytoDyn The Next Generation of Monoclonal Antibody Therapy
CytonDyn is committed to enhancing the lives of patients through target specific medicine. Their team is focused on developing Leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug for a variety of indications.
#CYDY
Annual shareholders meeting update.
https://www.cytodyn.com/newsroom/press-releas...meeting-of
(0)
(0)
